NEW YORK, May 23 (Reuters) - Valeant Pharmaceuticals Inc
plans to lower its debt by at least $1.5 billion this
year, Chief Executive Officer Joseph Papa said on Monday during
his first large meeting with investors since taking the top job
three weeks ago.
Read more
No comments:
Post a Comment